Valuation: Inogen, Inc.

Market Cap 158M 141M 131M 120M 226M 15.23B 228M 1.59B 616M 7.79B 595M 582M 24.99B P/E 2026 *
-7.8x
P/E 2027 * -12.6x
Enterprise Value 158M 141M 131M 120M 226M 15.23B 228M 1.59B 616M 7.79B 595M 582M 24.99B EV / Sales 2026 *
0.44x
EV / Sales 2027 * 0.43x
Free-Float
87.05%
Yield 2026 *
-
Yield 2027 * -
1 day-0.17%
1 week+11.38%
Current month+13.28%
1 month+9.54%
3 months-9.55%
6 months-3.86%
Current year-11.16%
1 week 5.26
Extreme 5.265
6.16
1 month 5.04
Extreme 5.045
6.16
Current year 5.04
Extreme 5.045
7.67
1 year 5.04
Extreme 5.045
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
44.3
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 09/11/2023
Director of Finance/CFO 48 05/04/2026
Chief Operating Officer 56 05/07/2026
Director TitleAgeSince
Director/Board Member 66 05/08/2014
Chairman 65 28/12/2021
Director/Board Member 59 21/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Controller/Auditor

1,500 0.0057%
01/09/26 Free

General Counsel

46,443 0.1750%
01/09/26 Free

Chief Executive Officer

1,500 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%+11.38%-30.98%+22.21% 158M
+0.84%-3.74%-27.56%+1.79% 169B
-0.07%-2.55%-11.59%+12.86% 110B
+0.90%+1.13%-25.66%+3.60% 106B
-1.24%-0.76%-49.50%-12.08% 73.87B
-0.24%+0.69%+2.08%+71.44% 58.98B
-0.86%+2.96%+12.91%+61.58% 51.28B
-0.71%-3.82%-8.68%-31.71% 48.16B
+0.12%-0.17%-17.87%+21.91% 40.84B
-1.01%-1.45%+27.31%-6.14% 32.21B
Average -0.24%+0.37%-12.95%+14.54% 69.03B
Weighted average by Cap. +0.03%-1.29%-17.07%+11.23%

Financials

2026 *2027 *
Net sales 356M 317M 296M 269M 508M 34.26B 513M 3.58B 1.39B 17.52B 1.34B 1.31B 56.21B 373M 331M 309M 282M 531M 35.82B 536M 3.74B 1.45B 18.31B 1.4B 1.37B 58.77B
Net income -20.8M -18.48M -17.25M -15.72M -29.65M -2B -29.93M -209M -80.89M -1.02B -78.09M -76.4M -3.28B -13.35M -11.86M -11.07M -10.09M -19.03M -1.28B -19.21M -134M -51.92M -656M -50.12M -49.03M -2.11B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
02/10/26 US$5.970 -0.17% 426,817
01/10/26 US$5.980 +13.47% 1,105,406
30/09/26 US$5.270 -1.86% 267,486
29/09/26 US$5.370 -1.29% 231,991
28/09/26 US$5.440 +1.49% 301,882
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.970USD
Average target price
12.00USD
Spread / Average Target
+101.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock